Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030
RSS SUMMARY · AGGREGATED FROM TWSJ
The drugmaker’s on-market pharma portfolio, together with drugs for lupus, breast cancer and multiple sclerosis, should offset generic competition until 2030, Chief Executive Thomas Schinecker said.
The drugmaker’s on-market pharma portfolio, together with drugs for lupus, breast cancer and multiple sclerosis, should offset generic competition until 2030, Chief Executive Thomas Schinecker said.
The drugmaker’s on-market pharma portfolio, together with drugs for lupus, breast cancer and multiple sclerosis, should offset generic competition until 2030, Chief Executive Thomas Schinecker said.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
Tech
SAP Launches Unified AI, Automation Suite
TWSJ·38m ago·3 min read
Business
Streaming Platforms Are Swallowing the TV Ad Market
TWSJ·1h ago·3 min read
Business
PayPal Reaches $30 Million Pact With Justice Department Over Minority Funding
TWSJ·1h ago·3 min read
Business
European Gas Rises on Stalled U.S.-Iran Talks, Tighter Supplies
TWSJ·2h ago·3 min read
Related
On this beat
Health
How physical activity can boost your brain health and reduce dementia risk
CBS NEWS·47m ago·3 min read
Health
Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
CNBC·54m ago·3 min read
Health
Parents sue OpenAI over teen’s death after he used ChatGPT to get drug info
CBS NEWS·2h ago·3 min read
Health
Cucumber Sandwich Bites (Grain-Free Options)
WELNESS MAMA·4h ago·3 min read